Following the recent publication of Pitt Street Research’s initiation report on Race Oncology, the company’s founder Stuart Roberts sat down with Race CEO Phil Lynch and Dr Daniel Tillett in Melbourne recently for a chat.

The discussion provides an insight into the multiple opportunities the Company believes Zantrene offers, and further explanation of the various clinical studies underway and the positive results to date.

You can watch a recording of the discussion here https://lnkd.in/dZd2Gqdh